NTRK Therapy among Different Types of Cancers, Review and Future Perspectives

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• Neurotrophic tyrosine receptor kinase (NTRK) is a key target in oncogenic signaling pathways.
• NTRK inhibitors have gained FDA approval for treating various malignancies, transforming oncology.
• Accurate detection of NTRK gene fusions is vital for patient selection in targeted therapy.

Purpose of the Study:

• To review the clinical utility of different NTRK gene fusion detection methods.
• To discuss the effectiveness of NTRK inhibitors across various cancer types.
• To explore challenges and potential improvements in NTRK inhibitor therapy.

Main Methods:

• Literature review of clinical trials and diagnostic methods for NTRK gene fusions.
• Analysis of sensitivity, specificity, and accessibility of various detection techniques.
• Evaluation of NTRK inhibitor efficacy and resistance mechanisms in different malignancies.

Main Results:

• NTRK inhibitors have significantly impacted cancer treatment, with groundbreaking trials like NAVIGATE.
• Various methods for NTRK gene fusion detection exist, each with distinct clinical utility.
• Resistance mechanisms and side effects present challenges to the widespread efficacy of NTRK inhibitors.

Conclusions:

• Early and accurate detection of NTRK gene fusions is critical for successful targeted therapy.
• Understanding resistance mechanisms is essential for optimizing NTRK inhibitor efficacy.
• Further research is needed to overcome current limitations and enhance NTRK inhibitor-based cancer treatments.